Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 6467375, 12 pages
http://dx.doi.org/10.1155/2016/6467375
Research Article

Linking CD11b+ Dendritic Cells and Natural Killer T Cells to Plaque Inflammation in Atherosclerosis

1Laboratory of Physiopharmacology, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, 2610 Antwerp, Belgium
2Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium
3Hospital Network Antwerp, 2020 Antwerp, Belgium
4Department of Thoracic and Vascular Surgery, University Hospital Antwerp, 2650 Antwerp, Belgium
5StatUa Center for Statistics, University of Antwerp, 2650 Antwerp, Belgium
6Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute, Faculty of Medicine and Health Sciences, University of Antwerp, 2650 Antwerp, Belgium

Received 27 October 2015; Revised 30 December 2015; Accepted 12 January 2016

Academic Editor: Daniel Benitez-Ribas

Copyright © 2016 Miche Rombouts et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • Caitríona Grönberg, Jan Nilsson, and Maria Wigren, “Recent advances on CD4 + T cells in atherosclerosis and its implications for therapy,” European Journal of Pharmacology, 2017. View at Publisher · View at Google Scholar
  • Nasimudeen R. Jabir, Chelapram K. Firoz, Farid Ahmed, Mohammad A. Kamal, Salwa Hindawi, Ghazi A. Damanhouri, Hussein A. Almehdar, and Shams Tabrez, “Reduction in CD16/CD56 and CD16/CD3/CD56 Natural Killer Cells in Coronary Artery Disease,” Immunological Investigations, pp. 1–10, 2017. View at Publisher · View at Google Scholar
  • Gijs H.M. van Puijvelde, and Johan Kuiper, “NKT cells in cardiovascular diseases,” European Journal of Pharmacology, 2017. View at Publisher · View at Google Scholar
  • Na Zhang, Min Zhang, Ru-Tao Liu, Peng Zhang, Chun-Lin Yang, Long-Tao Yue, Heng Li, Yong-Kang Li, and Rui-Sheng Duan, “Statins reduce the expressions of Tim-3 on NK cells and NKT cells in atherosclerosis,” European Journal of Pharmacology, 2017. View at Publisher · View at Google Scholar
  • Peter M. Mihailovic, Wai Man Lio, Juliana Yano, Xiaoning Zhao, Jianchang Zhou, Kuang-Yuh Chyu, Prediman K. Shah, Bojan Cercek, and Paul C. Dimayuga, “The cathelicidin protein CRAMP is a potential atherosclerosis self-antigen in ApoE(-/-) mice,” Plos One, vol. 12, no. 11, pp. e0187432, 2017. View at Publisher · View at Google Scholar
  • Miche Rombouts, Nathalie Cools, Mandy O. J. Grootaert, Flore de Bakker, Ilse Van Brussel, An Wouters, Guido R. Y. De Meyer, Benedicte Y. De Winter, and Dorien M. Schrijvers, “Long-Term Depletion of Conventional Dendritic Cells Cannot Be Maintained in an Atherosclerotic Zbtb46-DTR Mouse Model,” Plos One, vol. 12, no. 1, pp. e0169608, 2017. View at Publisher · View at Google Scholar
  • Sara Nullens, Joris De Man, Chris Bridts, Didier Ebo, Sven Francque, and Benedicte De Winter, “Identifying Therapeutic Targets for Sepsis Research: A Characterization Study of the Inflammatory Players in the Cecal Ligation and Puncture Model,” Mediators of Inflammation, vol. 2018, pp. 1–17, 2018. View at Publisher · View at Google Scholar
  • Pu Fang, Xinyuan Li, Jin Dai, Lauren Cole, Javier Andres Camacho, Yuling Zhang, Yong Ji, Jingfeng Wang, Xiao-Feng Yang, and Hong Wang, “Immune cell subset differentiation and tissue inflammation,” Journal of Hematology & Oncology, vol. 11, no. 1, 2018. View at Publisher · View at Google Scholar
  • Holger Winkels, Erik Ehinger, Yanal Goshesh, Dennis Wolf, and Klaus Ley, “Atherosclerosis in the single-cell era,” Current Opinion in Lipidology, pp. 1, 2018. View at Publisher · View at Google Scholar